Press Release: Arisaph Pharmaceuticals : Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates

BOSTON, Sept. 29, 2014 /PRNewswire/ -- Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business...